{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-158355","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.417866+00:00","generated_at":"2026-06-01T05:18:44.371012+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vaxcyte shareholders re-elect Class I directors, ratify Deloitte as auditor, approve say-on-pay","bullets":["Annie Drapeau re-elected with 82,886,170 votes for; Teri Loxam with 96,840,846; Carlos Paya with 96,685,408.","Ratification of Deloitte & Touche as auditor for FY 2024: 103,807,993 for, 14,745 against, 24,027 abstain.","Non-binding advisory vote on executive compensation approved: 91,072,269 for, 7,934,248 against, 23,235 abstain.","Three Class I directors to serve until 2027 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-158355","json":"https://secwatch.observer/filing/0001193125-24-158355.json","markdown":"https://secwatch.observer/filing/0001193125-24-158355.md","text":"https://secwatch.observer/filing/0001193125-24-158355.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000119312524158355/0001193125-24-158355-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000119312524158355/d741791d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:18:44.371012+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}